T‐cell depletion in bone marrow transplantation

Anna Butturini,Robert Peter Gale

DOI: https://doi.org/10.1111/j.1399-0012.1989.tb00170.x

1989-06-01

Clinical Transplantation

Abstract:T‐cell depletion can prevent graft‐versus‐host disease (GvHD) following bone marrow transplantation. Adverse consequences, however, including graft rejection and GvHD have been reported. We reviewed data from 36 trials of T‐cell depletion involving 924 transplant recipients worldwide. Results were compared with more than 3000 recipients of non‐T‐cell depleted grafts. These data indicate that T‐cell depletion reduced the incidence of GvHD from about 45% to about 10% in HLA‐identical transplants. However, the incidence of graft rejection increased from 1% to about 10%. The risk of leukemia relapse increased from about 15% to about 40%. Similar trends were observed for HLA‐nonidentical transplants. Thus, T‐cell depletion is effective in decreasing GvHD but is associated with adverse consequences including graft rejection and leukemia relapse. New approaches to the problems raised by T‐cell depletion are required for survival to improve.

surgery,transplantation